Boehringer Targets Hearing Loss In First China Pharma R&D collaboration
Executive Summary
Joining a growing number of its multinational peers tapping into China’s expanding innovative capabilities, Boehringer Ingelheim has teamed up with an academic research group to develop novel stem cell therapies for hearing loss, further encouraged by new state support for regenerative medicine.